[OP0011] Poor remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept - results from the nationwide Danish "DANBIO" database

M. Østergaard, J. Unkerskov, N.S. Krogh, M. Friis, T. Ravn, A. Petri, L.S. Andersen, U. Tarp, A. Hansen, M.L. Hetland

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date2005
Publication statusPublished - 2005
EventEuropean League Against Rheumatism (EULAR) congres - Wien, Austria
Duration: 24. Aug 2010 → …

Conference

ConferenceEuropean League Against Rheumatism (EULAR) congres
CountryAustria
CityWien
Period24/08/2010 → …

Cite this

Østergaard, M., Unkerskov, J., Krogh, N. S., Friis, M., Ravn, T., Petri, A., Andersen, L. S., Tarp, U., Hansen, A., & Hetland, M. L. (2005). [OP0011] Poor remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept - results from the nationwide Danish "DANBIO" database. Poster session presented at European League Against Rheumatism (EULAR) congres, Wien, Austria.